anmelden
AstraZeneca Aktie
140,55
EUR
-0,90
EUR
-0,64
%
140,10
EUR
-0,80
EUR
-0,57
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 220,08 Mrd. EUR
KGV 27,55 Div. Rendite 1,71%WKN 886455
ISIN GB0009895292
Symbol AZN
AI Analyse
Werbung
AstraZeneca Aktie Analyse
| 19.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 03.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 03.05.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.04.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 19.04.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.04.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.04.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 07.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 05.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 22.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 08.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 07.03.22 | AstraZeneca Buy | UBS AG | |
| 07.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.02.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 18.02.22 | AstraZeneca Buy | UBS AG | |
| 16.02.22 | AstraZeneca Buy | UBS AG | |
| 16.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.02.22 | AstraZeneca Overweight | Barclays Capital | |
| 14.02.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.02.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.02.22 | AstraZeneca Buy | UBS AG | |
| 10.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 31.01.22 | AstraZeneca Overweight | Barclays Capital | |
| 20.01.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 19.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.12.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 22.11.21 | AstraZeneca Buy | Kepler Cheuvreux | |
| 17.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.11.21 | AstraZeneca Buy | UBS AG | |
| 15.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.11.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.11.21 | AstraZeneca Buy | UBS AG | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |
| 02.11.21 | AstraZeneca Buy | UBS AG | |
Werbung
Werbung
